Integris Health raises primary capital 

 Integris Health, a medical devices company, said it has raised an unspecified amount of primary capital from a consortium of prominent investors, including Mukul Agarwal and India SME Fund. 

“This funding will support the company’s expansion into multiple therapeutic areas such as in-vitro diagnostics and laboratory solutions through strategic acquisitions and in-house product development initiatives,” the company said adding it was planning an IPO towards end of 2025.

Gurmit Singh Chugh, co-founder and chairman, Integris Health, said, “The Indian med-tech devices industry is experiencing an unprecedented growth phase akin to the transformative opportunities witnessed by the Indian pharmaceutical sector in the early 2000s. The company is poised to spearhead this global evolution, leveraging its cutting-edge R&D, strategic partnerships, robust distribution capabilities, and the cost-efficiency of Indian manufacturing.”

Avnish Mehra, vice-chairman of Everstone Capital, said, “The company’s growth trajectory reflects our commitment to building scalable healthcare platforms. This funding combined with the company’s proven product development capabilities, consistent organic growth and acquisition track record reinforces its position as a transformative med-tech devices business serving hospitals and laboratories globally.”